Dr Mohammad Afshar (Founder and CEO) is presenting our Onco KEM® platform at WIN 2015 on 29 June. Dr. Mariana Guergova-Kuras (CTO) and Dr David Morley (VP Computational Technology) will also be attending the symposium for a fascinating two days of cutting-edge presentations and discussions with global key opinion leaders in cancer research and precision cancer medicine.

PLENARY SESSION 4: Next generation of trials with targeted therapies

WINTHER trial: An SME driven EUFP7 program to create an industry standard tool to optimize therapeutic decision making, Mohammad Afshar, Tersan Pharmaceuticals Ltd, Paris, France